Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2015 (2015), Article ID 458151, 6 pages
Case Report

Transapical Implantation of a 2nd-Generation JenaValve Device in Patient with Extremely High Surgical Risk

Cardiac Unit and Cardiovascular Surgery Department, Otamendi Hospital, Azcuènaga 870, C1115AAB Buenos Aires, Argentina

Received 1 June 2015; Accepted 21 July 2015

Academic Editor: Henri Justino

Copyright © 2015 Juan Mieres et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Transcatheter Aortic Valve Replacement (TAVR) is performed in patients who are poor surgical candidates. Many patients have inadequate femoral access, and alternative access sites have been used such as the transapical approach discussed in this paper. We present an elderly and fragile patient not suitable for surgery for unacceptable high risk, including poor ventricular function, previous myocardial infarction with percutaneous coronary intervention, pericardial effusion, and previous cardiac surgery with replacement of mechanical mitral valve. Transapical aortic valve replacement with a second-generation self-expanding JenaValve is performed. The JenaValve is a second-generation transapical TAVR valve consisting of a porcine root valve mounted on a low-profile nitinol stent. The valve is fully retrievable and repositionable. We discuss transapical access, implantation technique, and feasibility of valve implantation in this extremely high surgical risk patient.